✦ LIBER ✦

Characterization of virologic escape in hepatitis C virus genotype 1b patients treated with the direct-acting antivirals daclatasvir and asunaprevir

✍ Scribed by Karino, Yoshiyasu; Toyota, Joji; Ikeda, Kenji; Suzuki, Fumitaka; Chayama, Kazuaki; Kawakami, Yoshiiku; Ishikawa, Hiroki; Watanabe, Hideaki; Hernandez, Dennis; Yu, Fei; McPhee, Fiona; Kumada, Hiromitsu

Book ID: 121407839
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 952 KB
Volume: 58
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2012.11.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Estimating the Long-Term Clinical and Ec

Estimating the Long-Term Clinical and Economic Outcomes of Daclatasvir Plus Asunaprevir in Difficult-to-Treat Japanese Patients Chronically Infected with Hepatitis C Genotype 1b

✍ McEwan, Phil; Ward, Thomas; Webster, Samantha; Yuan, Yong; Kalsekar, Anupama; Br 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 702 KB

Ultradeep Sequencing Study of Chronic He

Ultradeep Sequencing Study of Chronic Hepatitis C Virus Genotype 1 Infection in Patients Treated with Daclatasvir, Peginterferon, and Ribavirin

✍ Murakami, E.; Imamura, M.; Hayes, C. N.; Abe, H.; Hiraga, N.; Honda, Y.; Ono, A. 📂 Article 📅 2014 🏛 American Society for Microbiology 🌐 English ⚖ 790 KB

Emergence of resistant variants detected

Emergence of resistant variants detected by ultra-deep sequencing after asunaprevir and daclatasvir combination therapy in patients infected with hepatitis C virus genotype 1

✍ Kosaka, K.; Imamura, M.; Hayes, C. N.; Abe, H.; Hiraga, N.; Yoshimi, S.; Murakam 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 312 KB

Dual therapy with the nonstructural prot

Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b–infected null responders

✍ Kazuaki Chayama; Shoichi Takahashi; Joji Toyota; Yoshiyasu Karino; Kenji Ikeda; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 905 KB

The following corrections have since been made: ''BMS-790052'' has been replaced throughout with ''daclatasvir''; ''BMS-50032'' has been replaced throughout with ''asunaprevir''. The article has been updated online and in print.

1193 A DESCRIPTION OF VIROLOGIC ESCAPE I

1193 A DESCRIPTION OF VIROLOGIC ESCAPE IN HCV GENOTYPE 1-INFECTED PATIENTS TREATED WITH DACLATASVIR (BMS-790052) IN COMBINATION WITH RIBAVIRIN AND PEGINTERFERON ALFA-2A OR PEGINTERFERON ALFA-2B

✍ McPhee, F.; Hernandez, D.; Yu, F.; Ueland, J.; Chayama, K.; Toyota, J.; Izumi, N 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Effects of interferon treatment on the a

Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype 1b- and genotype 2c-infected patients

✍ G Missale; E Cariani; V Lamonaca; A Ravaggi; A Rossini; R Bertoni; M Houghton; Y 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB 👁 3 views

The viral genotype may influence the response to interferon sion and more efficient antiviral immune response, is still (IFN) treatment in chronic hepatitis C virus (HCV) infection. unclear. To characterize potential mechanisms responsible for this ef-Several factors including viral load, disease se